NASDAQ: CRDL - Cardiol Therapeutics Inc.

半年間の収益性: -47.2%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Cardiol Therapeutics Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis.

さらに詳しく
The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2019-01-15
ISIN CA14161Y2006
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.cardiolrx.com
Цена ао 1.15
1日あたりの価格変動: -1.74% (1.15)
週ごとの価格変動: -3% (1.165)
月ごとの料金変更: -13.08% (1.3)
3ヶ月間の価格変動: -15.04% (1.33)
半年間の価格変動: -47.2% (2.14)
年間の価格変動: -24.67% (1.5)
3年間の価格推移: -14.39% (1.32)
5年間の価格推移: -61.95% (2.97)
年初からの価格変動: -13.74% (1.31)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 2.51 6
P/E 0 0
EV/EBITDA -1.23 0
合計: 3.25

効率

名前 意味 学年
ROA, % -76.64 0
ROE, % -99.58 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0059 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 120.28 10
収益性 EPS, % 6.4 1
合計: 4.2
さらに詳しく

機関 音量 共有, %
MMCAP International, Inc. SPC 2953300 4.33
AdvisorShares Investments, LLC 1189978 1.75
Tejara Capital Ltd 1116676 1.64
AXS Investments, LLC 697651 1.02
Lion Street Advisors, LLC 192700 0.28
Bank of Montreal/Can/ 104479 0.15
We Are One Seven, LLC 100000 0.15
Laird Norton Trust Company, LLC 100000 0.15
Cambridge Investment Research Advisors Inc. 85201 0.12
Credit Suisse Ag/ 80000 0.12

ETF共有, %年間の利益率, %配当金, %
AdvisorShares Pure Cannabis ETF 6.51027 -3.73 1.68573
6.51-3.731.69



スーパーバイザー 役職 支払い 生年
Mr. David G. Elsley MBA President, CEO & Director 550.14k
Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA CFO, Corporate Secretary & Director 216.79k
Mr. Bernard Lim B.Sc. Chief Operating Officer 379.39k
Dr. Andrew Warwick Hamer M.D. Chief Medical Officer & Head of Research & Development 549.01k 1962 (63 年)
Trevor Burns Investor Relations N/A
Mr. John A. Geddes BSCPT, MBA Vice President of Corporate Development

住所: Canada, Oakville, 2265 Upper Middle Road East - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.cardiolrx.com